Cargando…

Reply to Letter to the Editor Regarding: “Myocarditis and Cardiac Complications Associated With COVID-19 and mRNA Vaccination”

Detalles Bibliográficos
Autores principales: Holland, David J., Stanton, Tony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349235/
https://www.ncbi.nlm.nih.gov/pubmed/35933261
http://dx.doi.org/10.1016/j.hlc.2022.07.002
_version_ 1784762086540181504
author Holland, David J.
Stanton, Tony
author_facet Holland, David J.
Stanton, Tony
author_sort Holland, David J.
collection PubMed
description
format Online
Article
Text
id pubmed-9349235
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).
record_format MEDLINE/PubMed
spelling pubmed-93492352022-08-04 Reply to Letter to the Editor Regarding: “Myocarditis and Cardiac Complications Associated With COVID-19 and mRNA Vaccination” Holland, David J. Stanton, Tony Heart Lung Circ Letter to the Editor Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). 2022-10 2022-08-04 /pmc/articles/PMC9349235/ /pubmed/35933261 http://dx.doi.org/10.1016/j.hlc.2022.07.002 Text en © 2022 Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Holland, David J.
Stanton, Tony
Reply to Letter to the Editor Regarding: “Myocarditis and Cardiac Complications Associated With COVID-19 and mRNA Vaccination”
title Reply to Letter to the Editor Regarding: “Myocarditis and Cardiac Complications Associated With COVID-19 and mRNA Vaccination”
title_full Reply to Letter to the Editor Regarding: “Myocarditis and Cardiac Complications Associated With COVID-19 and mRNA Vaccination”
title_fullStr Reply to Letter to the Editor Regarding: “Myocarditis and Cardiac Complications Associated With COVID-19 and mRNA Vaccination”
title_full_unstemmed Reply to Letter to the Editor Regarding: “Myocarditis and Cardiac Complications Associated With COVID-19 and mRNA Vaccination”
title_short Reply to Letter to the Editor Regarding: “Myocarditis and Cardiac Complications Associated With COVID-19 and mRNA Vaccination”
title_sort reply to letter to the editor regarding: “myocarditis and cardiac complications associated with covid-19 and mrna vaccination”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349235/
https://www.ncbi.nlm.nih.gov/pubmed/35933261
http://dx.doi.org/10.1016/j.hlc.2022.07.002
work_keys_str_mv AT hollanddavidj replytolettertotheeditorregardingmyocarditisandcardiaccomplicationsassociatedwithcovid19andmrnavaccination
AT stantontony replytolettertotheeditorregardingmyocarditisandcardiaccomplicationsassociatedwithcovid19andmrnavaccination